World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
98
Citations
35061
World Ranking
8922
National Ranking
4591

Jordan U. Gutterman publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jordan U. Gutterman sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 419 publications — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jordan U. Gutterman D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jordan U. Gutterman sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 98 D-Index — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Jordan U. Gutterman is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily intersects the fields of biochemistry, genetics, molecular biology, immunology, and microbiology, with particular contributions within several subfields such as molecular biology, immunology, cell biology, genetics, and biomedical engineering.

The scientist's work spans a range of important topics in biomedical research. These topics include:

  • Toxin Mechanisms and Immunotoxins
  • Sphingolipid Metabolism and Signaling
  • Cellular Transport and Secretion
  • Evolution and Genetic Dynamics
  • Slime Mold and Myxomycetes Research
  • Evolutionary Game Theory and Cooperation
  • Plant Biochemistry and Biosynthesis

Gutterman has an active publication record with papers appearing in several notable scientific journals. Recent papers include:

  • "Avicin G is a potent sphingomyelinase inhibitor and blocks oncogenic K- and H-Ras signaling," 2020, published in Scientific Reports
  • "Can natural selection and druggable targets synergize? Of nutrient scarcity, cancer, and the evolution of cooperation," 2020, published in BioEssays
  • "Abstract 1033: The anticancer compound avicin D targets lysosomal functions," 2021, published in Cancer Research

Throughout their work, Gutterman has frequently collaborated with several researchers, including Christian M. Garrido, Karen M. Henkels, Kristen M. Rehl, Liang Hong, and Yong Zhou. These collaborations have contributed to their publications and research activities in the biomedical sciences.

Their research has appeared mainly in the following scientific venues:

  • Scientific Reports
  • BioEssays
  • Cancer Research

Best Publications

  • Synthesis of Messenger RNAs for Transforming Growth Factors α and β and the Epidermal Growth Factor Receptor by Human Tumors

    Rik Derynck;David V. Goeddel;Axel Ullrich;Jordan U. Gutterman

  • The Molecular Genetics of Philadelphia Chromosome–Positive Leukemias

    Razelle Kurzrock;Jordan U. Gutterman;Moshe Talpaz

  • Cytokine therapeutics: lessons from interferon alpha.

    Jordan U. Gutterman

  • The Energy Sensing LKB1-AMPK Pathway Regulates p27kip1 Phosphorylation Mediating the Decision to Enter Autophagy or Apoptosis

    Jiyong Liang;Shan H. Shao;Shan H. Shao;Zhi Xiang Xu;Bryan Hennessy

  • Alpha Interferon for Induction of Remission in Hairy-Cell Leukemia

    Jorge R. Quesada;James M Reuben;John T. Manning;Evan M. Hersh

  • Hematologic Remission and Cytogenetic Improvement Induced by Recombinant Human Interferon AlphaA in Chronic Myelogenous Leukemia

    Moshe Talpaz;Hagop M. Kantarjian;Kenneth McCredie;Jose M. Trujillo

  • Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes.

    Saroj Vadhan-Raj;Michael Keating;Michael Keating;Anne Lemaistre;Anne Lemaistre;Walter N. Hittelman;Walter N. Hittelman

  • Clinical toxicity of interferons in cancer patients: a review.

    Jorge R. Quesada;Moshe Talpaz;Adan Rios;Razelle Kurzrock

  • Leukocyte Interferon-Induced Tumor Regression in Human Metastatic Breast Cancer, Multiple Myeloma, and Malignant Lymphoma

    Jordan U. Gutterman;George R. Blumenschein;Raymond Alexanian;Hwee-Yong Yap

  • Phase I Study of Recombinant Tumor Necrosis Factor in Cancer Patients

    Mark Blick;Stephen A. Sherwin;Michael Rosenblum;Jordan Gutterman

  • Recombinant leukocyte A interferon: pharmacokinetics, single-dose tolerance, and biologic effects in cancer patients.

    Jordan U. Gutterman;Seymour Fine;Jorge Quesada;Sandra J. Horning

  • 13-cis-Retinoic Acid and Interferon α -2a: Effective Combination. Therapy for Advanced Squamous Cell Carcinoma of the Skin

    Scott M. Lippman;David R. Parkinson;Loretta M. Itri;Randal S. Weber

  • Interferon-Alpha Produces Sustained Cytogenetic Responses in Chronic Myelogenous Leukemia: Philadelphia Chromosome-Positive Patients

    Moshe Talpaz;Hagop Kantarjian;Razelle Kurzrock;Jose M. Trujillo

  • Leukocyte interferon-induced myeloid cytoreduction in chronic myelogenous leukemia

    Moshe Talpaz;Kenneth B. McCredie;Giora M. Mavligit;Jordan U. Gutterman

  • Clinical investigation of human alpha interferon in chronic myelogenous leukemia.

    Moshe Talpaz;Hagop M. Kantarjian;Kenneth B. McCredie;Michael J. Keating

  • Renal cell carcinoma: antitumor effects of leukocyte interferon.

    Jorge R. Quesada;David A. Swanson;Antonio Trindade;Jordan U. Gutterman

  • Prognostic factors in metastatic breast cancer treated with combination chemotherapy.

    Kenneth D. Swenerton;Sewa S. Legha;Terry Smith;Gabriel N. Hortobagyi

  • A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemia

    Razelle Kurzrock;Mordechai Shtalrid;Paolo Romero;William S. Kloetzer

  • Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinoma.

    Jorge R. Quesada;Adan Rios;David Swanson;Patrick Trown

  • Interferon-Alpha Produces Sustained Cytogenetic Responses in Chronic Myelogenous Leukemia

    Moshe Talpaz;Hagop Kantarjian;Razelle Kurzrock;Jose M. Trujillo

Frequent Co-Authors

Evan M. Hersh
Evan M. Hersh The University of Texas MD Anderson Cancer Center
Razelle Kurzrock
Razelle Kurzrock Medical College of Wisconsin
Moshe Talpaz
Moshe Talpaz University of Michigan–Ann Arbor
Hagop M. Kantarjian
Hagop M. Kantarjian The University of Texas MD Anderson Cancer Center
Gerald P. Bodey
Gerald P. Bodey The University of Texas MD Anderson Cancer Center
Emil J. Freireich
Emil J. Freireich The University of Texas MD Anderson Cancer Center
Gabriel N. Hortobagyi
Gabriel N. Hortobagyi The University of Texas MD Anderson Cancer Center
Michael J. Keating
Michael J. Keating The University of Texas MD Anderson Cancer Center
Terry L. Smith
Terry L. Smith The University of Texas MD Anderson Cancer Center
George R. Blumenschein
George R. Blumenschein The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens up a variety of alternative and complementary pathways that can be pursued online. For those passionate about health and diet, there are online nutrition degree programs that prepare students for roles in wellness, public health, and medical nutrition therapy.

Students interested in healthcare leadership might consider cahme-accredited online mha programs. These programs equip graduates with advanced management and administrative skills needed for roles in hospitals, health systems, and nonprofit organizations.

For registered nurses looking to expand their credentials without the need for additional clinical requirements, rn to bsn programs no clinicals provide a flexible route to complete your bachelor’s degree and open doors to more advanced nursing positions.

Those seeking the highest levels of nursing qualification can consider short dnp programs that allow experienced nurses to earn a Doctor of Nursing Practice in less time and fully online.

Each of these online degree options fosters specialized skills and creates new career opportunities, making them excellent choices for students committed to making a difference in healthcare—whether at the bedside, in executive offices, or through health education.

Best Scientists Citing Jordan U. Gutterman

Trending Scientists

Recently Published Articles